- Home
- MTEN vs SNSE Comparison
MTEN vs SNSE Comparison
Compare MTEN & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | SNSE |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 13.9M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MTEN | SNSE |
|---|---|---|
| Price | $0.02 | $11.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $72.50 |
| AVG Volume (30 Days) | ★ 92.2M | 74.6K |
| Earning Date | 10-01-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,735,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.63 | N/A |
| 52 Week Low | $0.03 | $5.00 |
| 52 Week High | $26.03 | $18.35 |
Technical Indicators
Market Signals| Indicator | MTEN | SNSE |
|---|---|---|
| Relative Strength Index (RSI) | 23.33 | 57.32 |
| Support Level | $0.03 | $9.32 |
| Resistance Level | $0.03 | $12.00 |
| Average True Range (ATR) | 0.21 | 1.13 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 0.13 | 80.57 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).